As per Future Market Insights’ latest industry analysis, the global viral RNA extraction kit market was around US$ 200.6 million in 2022 and is projected to exhibit a CAGR growth of close to 7.2% over the forecast period, with an estimated valuation of US$ 421.4 million by the end of 2033.
Viral RNA extraction is crucial in molecular diagnostic testing for infectious diseases caused by RNA viruses. The increasing demand for accurate and rapid testing for viral infections, such as COVID-19, influenza, hepatitis, HIV, and other emerging viral diseases drives the market.
Request Your Sample Report of Viral RNA Extraction Kit Market enriched with captivating data visualizations.
Significant progress has been made in cancer diagnosis using next-generation sequencing (NGS) technology to better understand the genomic profile of patients and tumour types. In recent years, NGS-based diagnostics profiling somatic mutations in tumours have shown clinical utility and favorable cost-effectiveness in cancer treatment.
As more effort is being spent on the extraction of biomolecules, continual technological changes are happening these days to improve the extraction process for targeted molecules. Automated extraction systems tend to be specifically designed instruments that help simplify and increase the output of nucleic acid extraction.
- The QIAcube Connect system fully automates QIAGEN spin-column extraction and purification protocols through a user-friendly interface. The automated system facilitates the utilization of over 80 QIAGEN kits, which includes more than 140 standard protocols commonly employed for various applications.
In general, the aforementioned factors are facilitating the expansion of the viral RNA extraction kit market and are anticipated to sustain the need for efficient and inventive alternatives in the predictable future.
Key Takeaways from Viral RNA Extraction Kit Market Study
- Nasal washes and swab is the leading segment as sample type among patients and professionals, and held about 9% revenue share in the global market in 2022 due to their high efficacy and specificity.
- By application, disease diagnosis is leading in the global viral RNA extraction kit market. It is expected to continue to do so with a projected CAGR rate of 5% during the forecasted years because viral RNA extraction kits play a crucial role in enabling accurate viral detection and diagnosis, making disease diagnosis the most widely used application for these kits.
- By end user, diagnostic laboratories are leading in the global viral RNA extraction kit market and are expected to continue to do so with a projected CAGR of 6% during the forecasted years due to the ease availability of testing kits in the diagnostic laboratories.
- By region, North America is leading in the global viral RNA extraction kit market. It is expected to continue to do so with a projected CAGR of 8% during the forecasted years due to research and development and academic and educational institutions.
“Disease diagnosis and surveillance using viral RNA extraction kits is creating lucrative potential for the market to grow” says an analyst of Future Market Insights.
Viral RNA Extraction Kit Market Competition
Key players in the viral RNA extraction kit market commonly employ strategic initiatives such as partnerships, acquisitions, and mergers to enhance their business operations. Prominent industry participants focus on implementing tactics such as augmenting revenue and leveraging cutting-edge technology to develop unique offerings.
- In June of 2020, Omega Bio-tek, Inc. announced the Mag-Bind a Viral RNA Xpress Kit. This kit facilitates the rapid and dependable isolation of Viral RNA from swab specimens.
- Beckman Coulter announced the release of the RNAdvance Viral XP Extraction Kit in November of 2020. The validation of the kit for RNA extraction from swab samples in high-throughput research processes has been conducted by iRepertoire, and it has been determined to be suitable. The product in question is intended for utilization in the context of quantitative real-time polymerase chain reaction (qRT-PCR).
Get Ahead with Comprehensive Viral RNA Extraction Kit Market Information – Purchase Now! @
https://www.futuremarketinsights.com/checkout/12149
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the viral RNA extraction kit market in its latest study, presenting a historical demand assessment of 2017– 2022 and projections for 2023 – 2033. The global viral RNA extraction kit market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The research study is based on the viral RNA extraction kits market – by sample type (nasal washes and swabs, sputum, saliva, fecal & and stool, urine, blood, tissues and others), by application (disease diagnosis, drug discovery, cancer research, cDNA library and others), by end-user (hospitals, academic & research institutes, pharmaceutical & biotechnology companies, clinical research organizations, diagnostic laboratories and forensic labs) across seven regions of the world.
Some of the prominent market players of the Viral RNA Extraction Kit Market profiled by FMI are:
- QIAGEN N.V.
- Omega Bio-Tek
- Thermo Fisher Scientific
- F.Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories
- F.Hoffmann-La Roche Ltd.
- Promega Corporation
- Genaxxon Bioscience GmbH
- Agilent Technologies
Viral RNA Extraction Kit Market Segmentation:
By Product Type:
- Kits & panel
- Solutions & Reagents
- Instruments & devices
By Type:
- Messenger RNA Isolation
- Circulating Nucleic Acid Purification
- MicroRNA Isolation
- PCR Cleanup
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12149
By Method:
- Guanidinium-acid-phenol isolation
- Silica technology
- Density gradient centrifugation
- Magnetic bead technology
- Lithium chloride & urea purification
- Column chromatography
- Non-column isolation
By Indication:
- Viral genotyping, epidemiology, & infectious disease research
- Drug Development (New product development)
- Personalized Medicine approach
- Animal Research (specimen or species research)
- Agriculture & horticulture
- Diagnostics
By End-user:
- Diagnostic centers or labs
- Research Institutes (Educational centers)
- Biotechnological & pharmaceutical organizations
- CROs (Contract Research Organizations)
Region
- North America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
About the Author:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at Trending Reports in the Healthcare Domain:
Single-use Bioreactors Market: By 2033, the single-use bioreactors market is forecasted to attain a substantial worth of US$ 18.9 billion, with a projected valuation of US$ 4.5 billion by the conclusion of 2023
Endoscopic Closure Systems Market: The projected value of the worldwide endoscopic closure systems market for 2023 is estimated at approximately US$ 309.2 million, with a projected Compound Annual Growth Rate (CAGR) of 6.3%.
Knee Reconstruction Devices Market: By 2023, the worldwide knee reconstruction devices market is projected to achieve a value of approximately US$ 8.5 billion, showing a steady growth rate with a 4.3% CAGR from 2023 to 2033.
Oncology Information Systems Market: The projected scale of the oncology information systems market for 2022 was approximately US$ 2,593.4 million, and it is expected to reach around US$ 2,753.8 million in 2023.
Herpes Simplex Keratitis Treatment Market: In 2022, the projected value of the herpes simplex keratitis treatment market was US$ 4,237.2 million, and this figure is expected to rise to US$ 4,442.2 million in 2023.
Originally Published by:
https://www.chronicles24.com/index.php/2023/09/01/viral-rna-extraction-kit-market-a-lucrative-landscape-with-7-4-cagr-enroot-to-register-us-421-4-million-by-2033-future-market-insights-inc/
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
